• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Generics

    Caplin Steriles Secures USFDA Approval For Sodium Phosphate

    INDPHARMAPOST

    Appeals court sides with Pfizer in patent fight with Astellas

    FIERCE PHARMA

    Amgen Inc. v. Hospira, Inc. (Fed. Cir. 2019)

    PATENTDOCS

    Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications

    FEDERALREGISTER

    Eli Lilly & Co. v. Hospira, Inc. (Fed. Cir. 2019)

    PATENTDOCS

    Pfizer To Launch Several Drugs Despite Generic Headwinds

    BIOSIMILAR DEVELOPMENT

    BPCIA Litigation Updates: Bevacizumab, Trastuzumab, Filgrastim

    BIGMOLECULEWATCH

    Lawmaker urges Pfizer to sue over lethal injection procedure

    FIERCE PHARMA

    NEUPOGEN® (filgrastim): Amgen Inc. v. Hospira Inc. and Pfizer Inc.

    PATENT LITIGATION

    Precedex® (dexmedetomidine HCL): Baxter Healthcare Corporation v. Hospira

    PATENT LITIGATION

    PrecedexTM (Dexmedetomidine Hydrochloride): Hospira v. Gland Pharma

    PATENT LITIGATION

    PrecedexTM (Dexmedetomidine Hydrochloride): Hospira v. Jiangsu Hengrui Medicine

    PATENT LITIGATION

    Precedextm (Dexmedetomidine Hydrochloride): Hospira, Inc. v. Fresenius Kabi USA

    PATENT LITIGATION

    Remicade® ( Infliximab): Janssen Biotech V. Celltrion Healthcare & Hospira

    PATENT LITIGATION

    ‘Over 90%’ of industry thinks Pfizer will sell generics biz

    IN-PHARMA TECHNOLOGIST

    J&J: Biosimilars will not replicate generic levels of competition or substitution

    BIOPHARMA-REPORTER

    Generic alternative to Novartis` transdermal patch for Alzheimer`s hits the market

    FIERCE DRUG DELIVERY

    Hospira recall of ketorolac now close to 40 million vials

    FIERCE PHARMA MANUFACTURING

    Hospira has stellar Q1 as it works to resolve quality issues

    FIERCE PHARMA MFG

    Otsuka scrambles to persuade judge to block Abilify copycats

    FIERCE PHARMA

    Will Mylan`s $29B Bid Spur Other Perrigo Suitors To Enter The Fray?

    FIERCE PHARMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.